Cancer-Related Fatigue after Androgen Deprivation Therapy for Prostate Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria for androgen deprivation therapy-induced Cancer-Related Fatigue patients: 1) Confirmed diagnosis of prostate cancer and Cancer-Related Fatigue, currently undergoing androgen deprivation therapy; 2) Meets TCM diagnostic criteria for Qi and Blood Deficiency; 3) Male aged 45-85 years; 4) Expected survival =6 months; 5) Fatigue clearly caused by prostate cancer or related factors; 6) Conscious, cognitively normal, able to complete questionnaires; 7) Willing to participate and provide signed informed consent.
Exclusion criteria
Exclusion criteria: Exclusion Criteria: 1) Subjects meeting any of the following criteria will be excluded from the study: 2)Having severe primary diseases of the cardiovascular system, liver, kidney, lung, liver, and hematological system 3)Known allergy to any ingredient of Erdi Bazhen Decoction or the excipients used in the trial; 4)Patients with severe infection; 5)Concurrent presence of other malignant tumors; 6)In the judgment of the investigator, any condition that is inconsistent with the subject's best interest for participating in the study, or that may impede, restrict, or interfere with the protocol-specified assessments; 7)Legal disability (including blindness, deafness, muteness, intellectual disability) or mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue Improvement; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life Indicator;Functional Status;TCM Syndrome Score;Objective Lab's Indicators; | — |
Countries
China
Contacts
Chengdu University of Traditional Chinese Medicine Affiliated Hospital